FDA UNTITLED_LETTER - Valgene Incorporated - July 20, 2022
FDA UNTITLED_LETTER for Valgene Incorporated on July 20, 2022. Product: Drugs. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA UNTITLED_LETTER for Valgene Incorporated on July 20, 2022. Product: Drugs. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Valgene IncorporatedInspection Date
July 20, 2022
Product Type
Drugs
ID: 97f26ea8-d390-4314-85d0-abbff0656024
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox